Alzheimer’s Drugs Market Key Factors Driving Growth Insights and Forecast Analysis during 2017-2025

 

Alzheimer’s Drugs Market

During the forecast period, it is anticipated that the market for Alzheimer's disease will expand quickly. All mental and memory functions could be lost in the later stages of the illness. In the world, there are approximately 55 million people who have dementia, and each year, there are almost 10 million new cases, according to a report from the World Health Organization from September 2021. According to the same source, Alzheimer's disease accounts for 60–70% of all cases of dementia, making it the most prevalent type. Governments and non-governmental organisations are investing heavily in the development of diagnostics and treatments for the condition, which could spur Alzheimer’s Drugs Market growth, as a result of the rising prevalence of Alzheimer's disease in the world.

According To Coherent Market Insights, The Global Alzheimer’s Drugs Market Was Valued At US$ 7 Billion In 2016 And Is Expected To Witness A CAGR Of 9.5% Over The Forecast Period (2017 - 2025).

The brain shrinks (atrophy) and brain cells degenerate in Alzheimer's disease, a neurological condition. Dementia, which is characterised by a progressive loss of cognitive, behavioral, and social abilities that reduces a person's ability to function independently, is most frequently caused by Alzheimer's disease. Medicines may momentarily alter or slow the progression of symptoms. For a short while, these treatments may be able to maintain function and independence in Alzheimer's disease patients. Numerous programmes and services are available for Alzheimer's patients and the people who care for them.

The global market for visual impairment is expanding mostly due to the increased prevalence of chronic disorders like dementia. The increasing cost of healthcare, which aids in enhancing its infrastructure, is a crucial element influencing the growth rate of the Alzheimer's disease market. The Alzheimer’s Drugs Market will also grow as awareness-raising efforts by public and private groups continue to rise. The market for drugs to treat and cure Alzheimer's disease will also grow as a result of rising medication development and high disposable income. Along with this, the ageing population is growing, and people's lifestyles are changing, which will accelerate Alzheimer’s Drugs Market growth.

Major Companies involved are- F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd.(Jerusalem), Sanofi (France), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Bayer AG (Germany), Eli Lilly and Company (US), Merck & Co., Inc. (US), Allergan (Ireland), Bristol-Myers Squibb Company (U.S.), Takeda Pharmaceutical Company Limited (Japan), Eisai Co., Ltd. (Japan), Merz Pharma (Germany), AstraZeneca (UK), Amgen Inc. (US), AbbVie Inc. (US), Biogen (US), Siemens Healthcare GmbH (Germany)

Comments

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Monochloroacetic Acid (MCAA) Market Is Estimated To Witness High Growth Owing To Increasing Demand for Surfactants and Herbicides